Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene Hugo description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 2233 to 2282 of 3228 in total
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2233\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TRIM3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
tripartite motif protein 3 (ring finger protein 22) (brain-expressed ring finger protein). [source:swissprot;acc:o75382]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
202.414\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.691\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00631\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2234\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
seven in absentia homolog 1. [source:refseq;acc:nm\_003031]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
223.608\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
225.005\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00625\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2235\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RARS2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
arginyl-trna synthetase-like; arginine-trna ligase. [source:refseq;acc:nm\_020320]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
200.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
199.711\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0062\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2236\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
protein regulator of cytokinesis 1; protein regulating cytokinesis 1. [source:refseq;acc:nm\_003981]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
222.959\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
224.337\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.00618\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2237\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
BRD3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
bromodomain-containing protein 3 (ring3-like protein). [source:swissprot;acc:q15059]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
222.965\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
224.343\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2238\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
BRD4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
bromodomain-containing protein 4 (hunk1 protein). [source:swissprot;acc:o60885]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
222.959\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
224.337\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2239\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
BRDT\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
testis-specific bromodomain protein. [source:refseq;acc:nm\_001726]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
222.958\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
224.336\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2240\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LRRC4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nag14 protein. [source:refseq;acc:nm\_022143]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
222.959\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
224.337\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2241\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
BRD2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
bromodomain-containing protein 2 (ring3 protein) (o27.1.1). [source:swissprot;acc:p25440]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
222.96\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
224.338\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2242\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ITM2B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
integral membrane protein 2b (transmembrane protein bri) [contains: abri/adan amyloid peptide]. [source:swissprot;acc:q9y287]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
209.197\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
207.915\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.00617\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2243\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ITM2C\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
integral membrane protein 2c (transmembrane protein bri3) (npd018). [source:swissprot;acc:q9nqx7]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2244\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ITM2A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
integral membrane protein 2a (e25 protein). [source:swissprot;acc:o43736]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2245\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FBLN2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
fibulin-2 precursor. [source:swissprot;acc:p98095]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
191.618\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
190.448\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00614\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2246\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MRPL18\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
mitochondrial ribosomal protein l18. [source:refseq;acc:nm\_014161]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
223.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
224.943\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0061\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2247\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ADI1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
sipl protein. [source:refseq;acc:nm\_018269]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
208.609\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
207.346\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00609\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2248\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KIF3C\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
kinesin-like protein kif3c. [source:swissprot;acc:o14782]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.045\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
220.377\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00608\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2249\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PC\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
pyruvate carboxylase, mitochondrial precursor (ec 6.4.1.1) (pyruvic carboxylase) (pcb). [source:swissprot;acc:p11498]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
181.091\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
179.999\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00607\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2250\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CSTF2T\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
likely ortholog of mouse variant polyadenylation protein cstf-64. [source:refseq;acc:nm\_015235]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
164.064\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
165.058\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.00606\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2251\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ENOPH1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
e-1 enzyme. [source:refseq;acc:nm\_021204]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
208.315\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
207.061\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2252\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ALAD\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
delta-aminolevulinic acid dehydratase (ec 4.2.1.24) (porphobilinogen synthase) (aladh). [source:swissprot;acc:p13716]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.185\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.498\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00605\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2253\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KIF3B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
kinesin-like protein kif3b (microtubule plus end-directed kinesin motor 3b) (hh0048). [source:swissprot;acc:o15066]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.047\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
220.371\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00604\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2254\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ubiquitin-conjugating enzyme e2-17 kda 3 (ec 6.3.2.19) (ubiquitin- protein ligase) (ubiquitin carrier protein) (e2(17)kb 3). [source:swissprot;acc:p47986]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
193.065\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
194.22\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00598\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2255\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ZFHX3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
alpha-fetoprotein enhancer binding protein (at motif-binding factor) (at-binding transcription factor 1). [source:swissprot;acc:q15911]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
202.366\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.57\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00595\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2256\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SIAH2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
seven in absentia homolog 2. [source:refseq;acc:nm\_005067]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
223.546\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
224.869\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00592\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2257\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
QPRT\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nicotinate-nucleotide pyrophosphorylase [carboxylating] (ec 2.4.2.19) (quinolinate phosphoribosyltransferase [decarboxylating]) (qaprtase) (qprtase). [source:swissprot;acc:q15274]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.563\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
211.315\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00591\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2258\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CDC37\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
hsp90 co-chaperone cdc37 (hsp90 chaperone protein kinase-targeting subunit) (p50cdc37). [source:swissprot;acc:q16543]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
223.888\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
225.191\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00582\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2259\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DMC1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
meiotic recombination protein dmc1/lim15 homolog. [source:swissprot;acc:q14565]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.391\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
214.606\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00569\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2260\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TSEN34\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
leng5 protein. [source:refseq;acc:nm\_024075]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
221.599\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
220.351\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.00566\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2261\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
WARS\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
tryptophanyl-trna synthetase (ec 6.1.1.2) (tryptophan--trna ligase) (trprs) (ifp53) (hwrs). [source:swissprot;acc:p23381]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2262\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ribulose-5-phosphate-3-epimerase; ribulose 5-phosphate 3-epimerase. [source:refseq;acc:nm\_006916]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2263\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
WARS2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
tryptophanyl-trna synthetase, mitochondrial precursor (ec 6.1.1.2) (tryptophan--trna ligase) (trprs) ((mt)trprs). [source:swissprot;acc:q9ugm6]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2264\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
thiamin pyrophosphokinase 1; mouse thiamin pyrophosphokinase homolog; thiamine pyrophosphokinase. [source:refseq;acc:nm\_022445]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2265\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MAD2L1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
mitotic spindle assembly checkpoint protein mad2a (mad2-like 1) (hsmad2). [source:swissprot;acc:q13257]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
211.597\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
210.416\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.00561\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2266\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ATP13A2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
probable cation-transporting atpase 1 (ec 3.6.1.-). [source:swissprot;acc:q9nq11]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2267\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TBP\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
tata box binding protein (transcription initiation factor tfiid) (tata-box factor) (tata sequence-binding protein) (tbp). [source:swissprot;acc:p20226]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2268\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TRIM2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
tripartite motif protein 2. [source:swissprot;acc:q9c040]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
202.312\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.437\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.00556\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2269\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PSMD10\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 10 (26s proteasome regulatory subunit p28) (gankyrin). [source:swissprot;acc:o75832]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.419\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.627\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2270\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MMS19\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
mms19-like (met18 homolog, s. cerevisiae); homolog of yeast mms19; mms19 (met18 s. cerevisiae)-like. [source:refseq;acc:nm\_022362]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
207.54\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
208.69\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00554\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2271\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FMO5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dimethylaniline monooxygenase [n-oxide forming] 5 (ec 1.14.13.8) (hepatic flavin-containing monooxygenase 5) (fmo 5) (dimethylaniline oxidase 5). [source:swissprot;acc:p49326]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
216.622\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
215.436\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.00551\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2272\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FMO6P\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
putative dimethylaniline monooxygenase [n-oxide forming] 6 (ec 1.14.13.8) (flavin-containing monooxygenase 6) (fmo 6) (dimethylaniline oxidase 6). [source:swissprot;acc:o60774]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2273\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MAP3K7IP1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
mitogen-activated protein kinase kinase kinase 7 interacting protein 1 (tak1-binding protein 1). [source:swissprot;acc:q15750]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.015\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
211.858\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00546\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2274\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PGD\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6-phosphogluconate dehydrogenase, decarboxylating (ec 1.1.1.44). [source:swissprot;acc:p52209]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.642\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
214.801\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00542\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2275\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DHDDS\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dehydrodolichyl diphosphate synthase. [source:refseq;acc:nm\_024887]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
207.319\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
208.44\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.00541\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2276\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FMO3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dimethylaniline monooxygenase [n-oxide forming] 3 (ec 1.14.13.8) (hepatic flavin-containing monooxygenase 3) (fmo 3) (dimethylaniline oxidase 3) (fmo form 2) (fmo ii). [source:swissprot;acc:p31513]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.613\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.448\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2277\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RCC1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
regulator of chromosome condensation (cell cycle regulatory protein). [source:swissprot;acc:p18754]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
191.936\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
190.909\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.00538\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2278\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ZEB2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
zinc finger homeobox protein 1b (smad interacting protein 1) (smadip1) (hrihfb2411). [source:swissprot;acc:o60315]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2279\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ZEB1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
transcription factor 8 (nil-2-a zinc finger protein) (negative regulator of il2). [source:swissprot;acc:p37275]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2280\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PSMA7\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
proteasome subunit alpha type 7 (ec 3.4.25.1) (proteasome subunit rc6-1) (proteasome subunit xapc7). [source:swissprot;acc:o14818]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.793\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
211.657\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00537\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2281\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SRRM2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
splicing coactivator subunit srm300; rna binding protein; at-rich element binding factor. [source:refseq;acc:nm\_016333]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
219.652\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
218.482\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.00536\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2282\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
U2AF1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
splicing factor u2af 35 kda subunit (u2 auxiliary factor 35 kda subunit) (u2 snrnp auxiliary factor small subunit). [source:swissprot;acc:q01081]\vspace{3pt}}&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the HGNC identifier if it exists

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/